IV 
110TH CONGRESS 
1ST SESSION 
H. CON. RES. 129 
Recognizing Susan G. Komen for the Cure on its leadership in the breast 
cancer movement on the occasion of its 25th anniversary. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2007 
Ms. EDDIE BERNICE JOHNSON of Texas submitted the following concurrent 
resolution; which was referred to the Committee on Energy and Commerce 
CONCURRENT RESOLUTION 
Recognizing Susan G. Komen for the Cure on its leadership 
in the breast cancer movement on the occasion of its 
25th anniversary. 
Whereas Nancy G. Brinker promised her dying sister, Susan 
G. Komen, that she would do everything in her power to 
end breast cancer; 
Whereas in Dallas, Texas, in 1982, that promise became 
Susan G. Komen for the Cure and launched the global 
breast cancer movement; 
Whereas Susan G. Komen for the Cure has grown to become 
the world’s largest grassroots network of breast cancer 
survivors and activists fighting to save lives, empower 
people, ensure quality care for all, and energize science 
to find the cure; 
VerDate Aug 31 2005 
04:17 Apr 26, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HC129.IH
HC129
hmoore on PRODPC68 with HMBILLS
•HCON 129 IH 
Whereas Susan G. Komen for the Cure has invested nearly 
$1,000,000,000 to fulfill its promise, becoming the larg-
est source of nonprofit funds in the world dedicated to 
curing breast cancer; 
Whereas Susan G. Komen for the Cure is committed to in-
vesting an additional $1,000,000,000 over the next dec-
ade in breast health care and treatment and in research 
to discover the causes of breast cancer and, ultimately, 
its cure; 
Whereas Susan G. Komen for the Cure serves the breast 
health and treatment needs of millions, especially under-
served women, through education and support to thou-
sands of community health organizations, with grants to 
date of more than $480,000,000; 
Whereas Susan G. Komen for the Cure has played a critical 
role in virtually every major advance in breast cancer re-
search over the past 25 years, with research investments 
to date of more than $300,000,000; 
Whereas Susan G. Komen for the Cure has advocated for 
more research on breast cancer treatment and preven-
tion, with the Federal Government now devoting more 
than $900,000,000 each year to breast cancer research, 
compared with $30,000,000 in 1982; 
Whereas Susan G. Komen for the Cure is a leader in the 
global breast cancer movement, with more than 100,000 
activists in 125 cities and communities, mobilizing more 
than 1,000,000 people every year through events like the 
Komen Race for the Cure Series—the world’s largest and 
most successful awareness and fundraising event for 
breast cancer; 
VerDate Aug 31 2005 
04:17 Apr 26, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HC129.IH
HC129
hmoore on PRODPC68 with HMBILLS
•HCON 129 IH 
Whereas Susan G. Komen for the Cure has been a strong 
supporter of the National Breast and Cervical Cancer 
Early Detection Program and the Mammography Quality 
Standards Act; 
Whereas in the last 25 years early detection and testing rates 
have increased, with nearly 75 percent of women over 40 
years of age now receiving regular mammograms, com-
pared with 30 percent of such women in 1982; 
Whereas in the last 25 years, the 5-year breast cancer sur-
vival rate has increased to 98 percent when the cancer 
is caught before it spreads beyond the breast, compared 
with 74 percent in 1982; 
Whereas without better prevention and a cure, 1 in 8 women 
in the United States will continue to suffer from breast 
cancer—a devastating disease with physical, emotional, 
psychological, and financial pain that can last a lifetime; 
Whereas without a cure, an estimated 5,000,000 Americans 
will be diagnosed with breast cancer—and more than 
1,000,000 could die—over the next 25 years; 
Whereas Susan G. Komen for the Cure is challenging individ-
uals, communities, States, and Congress to make breast 
cancer an urgent priority; 
Whereas Susan G. Komen for the Cure recognizes that in the 
world of breast cancer, the big questions are still without 
answers: what causes the disease and how it can be pre-
vented; and 
Whereas Susan G. Komen for the Cure is marking its 25th 
anniversary by recommitting to finish what it started and 
end breast cancer: Now, therefore, be it 
VerDate Aug 31 2005 
04:17 Apr 26, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HC129.IH
HC129
hmoore on PRODPC68 with HMBILLS
•HCON 129 IH 
Resolved by the House of Representatives (the Senate 
concurring), That Congress— 
(1) congratulates Susan G. Komen for the Cure 
on its 25th anniversary; 
(2) recognizes Susan G. Komen for the Cure as 
a global leader in the fight against breast cancer and 
commends the strides the organization has made in 
that fight; and 
(3) supports Susan G. Komen for the Cure’s 
commitment to attaining the goal of a world without 
breast cancer. 
Æ 
VerDate Aug 31 2005 
04:17 Apr 26, 2007
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HC129.IH
HC129
hmoore on PRODPC68 with HMBILLS